Detail of the clinical trial

Title of the trial A Three-part Study of Eltrombopag in Thrombocytopenic Subjects with Myelodysplastic Syndromes or Acute Myeloid Leukemia (Part 1: open-label, part 2: randomized, double-blind, part 3: extension). ASPIRE: A study of Eltormbopag In Myelodysplastic Syndromes and Acute Myeloid Leukemia.
EudraCT number 2011-000114-19
Protocol number TRC114968
Sponsor GlaxoSmithKline Research and Development Ltd., Global Regulatory Affairs, 1-3 Iron Bridge Road, Uxbridge, Middlesex, UB11 1BU UK
Indications Oncology
Diagnosis in Thrombocytopenic Subjects with Myelodysplastic Syndromes or Acute Myeloid Leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2011
Date of approval by Institute (SÚKL) 29.12.2011
Date of approval by EC 16.11.2011
Date of initiation CT in ČR 18.9.2012
Date of ending CT in ČR 29.1.2015
Notice
Sites Interní hemtolog. klinika Královské vinohrady Praha 10
ÚHKT, U Nemocnice 1 Praha 128 20
FN Brno, IHOK, Jihlavská 25 625 00

‹‹ Back to list